secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0000313143-24-000056
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics CTO Anila Lingamneni to depart on November 1, 2024
--------------------------------------------------------------

- Anila Lingamneni, EVP and Chief Technology Officer, will leave Haemonetics effective November 1, 2024.
- No replacement for the CTO role has been announced.
- The company expressed gratitude for Ms. Lingamneni's contributions and wished her success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000056/0000313143-24-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000056/hae-20240910.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer